The Appendix 4C quarterly report is due soon ( 31-3-2010 was reported on 23rd April 2010).
Outside of the pending NASDAQ listing and trial updates (Phase IIb and upcoming Phase III clinical registration trials for Cvac - its all about the trials ), hopefully MR also provides an update on US investor interest and related roadshows.
With all the recent publicity on Dendreon and immunotherapy and generally the Biotech sector( investors cant get enough of it !) IMO I think its a matter of time before PRR become a market darling.
On a seperate note IMO, PRR will be worthy candidates to present at an ASX Small to Mid Cap Global conference.
http://www.asx.com.au/professionals/asx-small-to-mid-cap-conferences.htm
Hopeully Prima get invited by the ASX in 2nd half 2011.
C'mon MR ...give us an update you legend !!!
(ps: DYOR before making any investment decisions).
31 march 2011 qrt report due ?
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |